(b) safety and stability
Disclosure of interest: Nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.01 - PREVENTION P2471 - ESOC25-388 COMPARARIVE EFFECTIVENESS AND SAFETY OF DIRECT ORAL ANTICOAGULANTS IN ATRIAL FIBRILLATION PATIENTS WITH DEMENTIA Sheng-Feng Sung 1 , Cheng-Yang Hsieh 2 , Hsin-Yi Yang 3 , Chen-Wen Fang 4,5 1 Division of Neurology, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan, 2 Department of Neurology, Tainan Sin Lau Hospital, Tainan City, Taiwan, 3 Clinical Data Center, Department of Medical Research, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan, 4 Department of Neurology, National Taiwan University Hospital, Yunlin branch, Douliu City, Taiwan, 5 Department of Biomedical Engineering, National Cheng Kung University., Tainan City, Taiwan Background and Aims: Stroke or systemic embolism is the most severe complication of atrial fibrillation (AF)
For instance, in terms of elucidating the ideal stimulation parameters, a consensus must be reached on identifying the montage that needs to be used, defining the intensity and polarity of the current delivered, and optimizing intervals between sessions and the number of sessions
Anti-inflammatory effects represent another crucial mechanism
